Clinical Trials Logo

Clinical Trial Summary

This study will assess the impact of cigarette constituent messages with and without FDA source and quit information in a randomized controlled trial. The investigators hypothesize that cigarette constituent messages will increase intention to quit compared to messages about littering cigarettes (the control). The investigators also hypothesize that constituent messages that include FDA source and quit information will increase intention to quit compared to messages without that information.


Clinical Trial Description

The Family Smoking Prevention and Tobacco Control Act delegates the U.S. Food and Drug Administration (FDA) to communicate the risks of smoking to the public, among other tobacco regulatory responsibilities. Little research exists about how FDA, as a regulatory agency, should develop and deliver these messages, and whether they should include their source information on the ads. This study will assess the impact of cigarette constituent messages with and without FDA source and quit information in a randomized controlled trial. Recruitment: People interested in participating will complete an online screener. Study staff will invite people eligible based on the screener to enroll in the study. Informed Consent: The consent form will be shared with people who are eligible based on the screener in the invitation email. At the beginning of the baseline survey, participants will again review the consent form and will be asked to provide consent in order to enroll in the study. Randomization: At the end of the baseline survey, survey software will randomly assign participants to one of the three study arms. Participants will have an equal chance of being randomized to each study arm. Assessment: Participants will complete 18 computer based surveys during the study. The first baseline survey will take around 20 minutes to complete on day 0. Participants will then receive a survey each morning for days 1-15 that will include behavior measures as well as their assigned study intervention. These surveys will take approximately 5 minutes to complete. Participants will then complete a 20-minute survey on day 16, and day 32. Detailed description of the intervention: Participants will receive an email with a link to a survey each morning for 15 days. During that survey they will be shown one message from their condition. Each condition has 5 messages that will be repeated 3 times in a counterbalanced order. Study investigators designed the messages. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03339206
Study type Interventional
Source UNC Lineberger Comprehensive Cancer Center
Contact
Status Completed
Phase N/A
Start date October 10, 2017
Completion date May 23, 2018

See also
  Status Clinical Trial Phase
Completed NCT04812795 - Project RESIST: Increasing Resistance to Tobacco Marketing Among Young Adult Sexual Minority Women Using Inoculation Message Approaches N/A
Completed NCT05499520 - Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women N/A
Completed NCT02785484 - Impact of Cigarette Pack Constituent Disclosures N/A
Recruiting NCT06072547 - Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART N/A
Completed NCT02301351 - Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors N/A
Recruiting NCT03568799 - 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules N/A
Completed NCT01359709 - Effects of Contingency Management and Nicotine Replacement Therapy on Youth Smoking Phase 1
Completed NCT02448225 - 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Phase 2
Completed NCT01921439 - OCAST Cessation Study N/A
Completed NCT02921282 - Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms